BASELINE ANALYSIS OF SURPASS STUDY, A PROSPECTIVE, NON-INTERVENTIONAL, MULTI-CENTER STUDY ON REAL-WORLD EFFECTIVENESS AND USAGE OF RECOMBINANT FACTOR VIII (SCT800, OMFILOCTOCOG ALFA) IN HEMOPHILIA A
第一作者单位:[1]Nanyang Med Coll, Affiliated Hosp 1, Nanyang, Peoples R China
推荐引用方式(GB/T 7714):
Dang H.,Lei P.,Yang L.,et al.BASELINE ANALYSIS OF SURPASS STUDY, A PROSPECTIVE, NON-INTERVENTIONAL, MULTI-CENTER STUDY ON REAL-WORLD EFFECTIVENESS AND USAGE OF RECOMBINANT FACTOR VIII (SCT800, OMFILOCTOCOG ALFA) IN HEMOPHILIA A[J].HAEMOPHILIA.2023,29:63-64.doi:10.1111/hae.14715.
APA:
Dang, H.,Lei, P.,Yang, L.,Sun, J.,Guo, Y....&Yang, R..(2023).BASELINE ANALYSIS OF SURPASS STUDY, A PROSPECTIVE, NON-INTERVENTIONAL, MULTI-CENTER STUDY ON REAL-WORLD EFFECTIVENESS AND USAGE OF RECOMBINANT FACTOR VIII (SCT800, OMFILOCTOCOG ALFA) IN HEMOPHILIA A.HAEMOPHILIA,29,
MLA:
Dang, H.,et al."BASELINE ANALYSIS OF SURPASS STUDY, A PROSPECTIVE, NON-INTERVENTIONAL, MULTI-CENTER STUDY ON REAL-WORLD EFFECTIVENESS AND USAGE OF RECOMBINANT FACTOR VIII (SCT800, OMFILOCTOCOG ALFA) IN HEMOPHILIA A".HAEMOPHILIA 29.(2023):63-64